EKF Diagnostics Holdings plc
EKF.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £121 | £123 | £127 | £144 |
| - Cash | £17 | £14 | £10 | £8 |
| + Debt | £1 | £1 | £1 | £4 |
| Enterprise Value | £106 | £110 | £118 | £140 |
| Revenue | £25 | £25 | £25 | £26 |
| % Growth | 1% | -0.9% | -2% | – |
| Gross Profit | £13 | £12 | £12 | £12 |
| % Margin | 50.2% | 49.4% | 47.8% | 48.2% |
| EBITDA | £6 | £6 | £6 | £4 |
| % Margin | 23.2% | 22.4% | 22% | 17.1% |
| Net Income | £2 | £4 | £2 | £3 |
| % Margin | 7.7% | 16.7% | 8.2% | 10.5% |
| EPS Diluted | 0.004 | 0.009 | 0.005 | 0.006 |
| % Growth | -53.3% | 100% | -23.3% | – |
| Operating Cash Flow | £5 | £6 | £8 | £4 |
| Capital Expenditures | -£0 | -£1 | -£1 | -£3 |
| Free Cash Flow | £4 | £5 | £6 | £0 |